
Building a new model for earlier Alzheimer’s diagnosis and care
A new clinical service for people at risk of or in the early stages of Alzheimer’s disease and other neurodegenerative conditions.

Scottish patients first in Europe to join new Alzheimer’s trial focused on reducing distress
Study is open for recruitment in Aberdeen and Edinburgh. Learn more

Introducing Gary White as Director of Operations
Life sciences expert Gary White appointed as Director of Operations at Scottish Brain Sciences to support company growth.

Alzheimer’s blood and biomarker testing service launched to support earlier diagnosis
Service will be available to clinicians and healthcare providers to support patient assessments and diagnosis. Contact the lab for more details.

International Brain Health Conference 2026 highlights
Highlights from the first International Brain Health Conference 2026.

Scottish Brain Sciences Biomarker Laboratory Achieves ISO 15189 Accreditation
Scottish Brain Sciences has achieved UKAS ISO 15189 accreditation, marking a major milestone in its mission to advance the early detection and diagnosis of Alzheimer’s disease.
